Literature DB >> 2820719

Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex.

A S Yee1, R Reichel, I Kovesdi, J R Nevins.   

Abstract

The precise binding site in the adenovirus E2 promoter for the E1A-inducible factor E2F was determined. DNase footprinting revealed two distinct regions of protection which spanned sequences from -33 to -49 and from -53 to -71. Chemical modifications of DNA further delineated nucleotides involved in DNA-protein contacts in each binding region. The E2F binding sites are clearly distinct from the binding site for another E2 promoter binding factor, located at -68 to -80, previously described by SivaRaman et al. [(1986) Proc. Natl. Acad. Sci. USA, 83, 5914-5918]. As determined by DNase footprinting using crude nuclear extracts, both factors were present in extracts of Ad5-infected cells and were found to bind simultaneously to their respective sites on the promoter. In contrast, E2F was not evident in extracts of uninfected cells, whereas there was no difference in the -68 to -80 footprint as a function of the extract. Thus, although multiple factors interact with the E2 promoter, only the E2F factor is unique to the infected extract. The implications of the formation of a multi-factor promoter complex as a possible mechanism of transcriptional regulation are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820719      PMCID: PMC553596          DOI: 10.1002/j.1460-2075.1987.tb02471.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

2.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes.

Authors:  L M Staudt; H Singh; R Sen; T Wirth; P A Sharp; D Baltimore
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

4.  Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences.

Authors:  N F Landolfi; J D Capra; P W Tucker
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

5.  Specific protein binding to the simian virus 40 enhancer in vitro.

Authors:  A G Wildeman; M Zenke; C Schatz; M Wintzerith; T Grundström; H Matthes; K Takahashi; P Chambon
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

6.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  An adenovirus E1a protein region required for transformation and transcriptional repression.

Authors:  J W Lillie; M Green; M R Green
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

8.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

9.  A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.

Authors:  K A Jones; J T Kadonaga; P J Rosenfeld; T J Kelly; R Tjian
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

10.  Multiple sequence motifs are involved in SV40 enhancer function.

Authors:  M Zenke; T Grundström; H Matthes; M Wintzerith; C Schatz; A Wildeman; P Chambon
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  58 in total

Review 1.  E2F1: a promising regulator in ovarian carcinoma.

Authors:  Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Bing Wei
Journal:  Tumour Biol       Date:  2016-01-09

2.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

Authors:  S W Hiebert; M Lipp; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Authors:  A S Yee; P Raychaudhuri; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

5.  The cellular transcription factor E2f requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E2A gene expression.

Authors:  L E Babiss
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation.

Authors:  R Reichel; S D Neill; I Kovesdi; M C Simon; P Raychaudhuri; J R Nevins
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Isolation and characterization of two novel, closely related ATF cDNA clones from HeLa cells.

Authors:  M Gaire; B Chatton; C Kedinger
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

8.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

Authors:  W Li; J Fan; D Hochhauser; D Banerjee; Z Zielinski; A Almasan; Y Yin; R Kelly; G M Wahl; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Authors:  R Morishita; G H Gibbons; M Horiuchi; K E Ellison; M Nakama; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.